Bioequivalence of Combination Products: Special Testing Challenges
Bioequivalence testing for combination products like FDCs, topical creams, and inhalers faces unique challenges due to drug interactions, delivery complexity, and inconsistent regulatory standards-delaying affordable generics and increasing costs for patients and manufacturers.
